111 Capital bought a new position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 2,602 shares of the semiconductor company's stock, valued at approximately $1,263,000.
Other institutional investors also recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC increased its holdings in Synopsys by 4.2% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 19,517 shares of the semiconductor company's stock worth $9,473,000 after purchasing an additional 783 shares in the last quarter. Centaurus Financial Inc. grew its holdings in shares of Synopsys by 24.7% during the fourth quarter. Centaurus Financial Inc. now owns 561 shares of the semiconductor company's stock worth $272,000 after purchasing an additional 111 shares during the last quarter. Siemens Fonds Invest GmbH increased its stake in shares of Synopsys by 17.2% in the fourth quarter. Siemens Fonds Invest GmbH now owns 8,795 shares of the semiconductor company's stock valued at $4,269,000 after buying an additional 1,288 shares during the period. Cim LLC raised its holdings in Synopsys by 0.4% in the 4th quarter. Cim LLC now owns 38,744 shares of the semiconductor company's stock valued at $18,805,000 after buying an additional 173 shares during the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Synopsys during the 4th quarter worth approximately $104,237,000. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Synopsys Trading Up 1.1%
NASDAQ SNPS traded up $5.09 during trading hours on Friday, hitting $460.08. 3,356,054 shares of the company's stock were exchanged, compared to its average volume of 1,140,593. The firm has a market cap of $71.39 billion, a price-to-earnings ratio of 31.69, a PEG ratio of 3.23 and a beta of 1.16. The stock has a 50-day simple moving average of $453.46 and a 200 day simple moving average of $485.14. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $624.80.
Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings data on Wednesday, May 28th. The semiconductor company reported $3.67 EPS for the quarter, topping the consensus estimate of $3.40 by $0.27. Synopsys had a net margin of 36.12% and a return on equity of 20.48%. The company had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.60 billion. During the same quarter last year, the firm posted $3.00 EPS. The company's quarterly revenue was up 10.3% on a year-over-year basis. On average, sell-side analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other news, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the transaction, the chief executive officer now owns 70,922 shares of the company's stock, valued at $32,890,077.50. This represents a 13.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Geus Aart De sold 15,705 shares of the business's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $444.42, for a total value of $6,979,616.10. Following the completion of the sale, the insider now directly owns 116,671 shares of the company's stock, valued at $51,850,925.82. The trade was a 11.86% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.62% of the company's stock.
Wall Street Analyst Weigh In
Several equities analysts have issued reports on the stock. Rosenblatt Securities decreased their price target on shares of Synopsys from $660.00 to $625.00 and set a "buy" rating for the company in a research report on Thursday. Stifel Nicolaus set a $550.00 price objective on Synopsys in a report on Monday, April 28th. KeyCorp set a $575.00 target price on Synopsys and gave the stock an "overweight" rating in a research report on Tuesday, May 20th. Piper Sandler reiterated an "overweight" rating and issued a $615.00 price target (down previously from $653.00) on shares of Synopsys in a research report on Thursday. Finally, Bank of America decreased their price target on Synopsys from $630.00 to $560.00 and set a "buy" rating for the company in a research note on Wednesday, April 16th. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. Based on data from MarketBeat, Synopsys has a consensus rating of "Moderate Buy" and a consensus target price of $609.64.
View Our Latest Analysis on Synopsys
About Synopsys
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.